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Abstract
Adamantinoma is a primary low-grade, malignant bone tumor that is predominantly located in the
mid-portion of the tibia. The etiology of the tumor is still a matter of debate. The initial symptoms
of adamantinoma are often indolent and nonspecific and depend on location and extent of the
disease. Histologically, classic adamantinoma is a biphasic tumor characterized by epithelial and
osteofibrous components that may be intermingled with each other in various proportions and
differentiating patterns. To assure the histological diagnosis, pathologists should employ
immunohistochemistry for demonstrating the sometimes sparse epithelial cell nests when the
radiological features are suggestive of adamantinoma. There is paucity of compiled data over
adamantinoma in the literature, hence authors tried to make a comprehensive review which must
be of use to beginners and trained pathologists. Our objective is to further define the
clinicoradiologic features and pathologic spectra of adamantinoma.
Background
Adamantinoma is a primary low-grade, malignant bone
tumor, of unknown histogenesis. However recent opinion
seems to suggest that adamantinoma is a tumor of epithe-
lial origin, based on ultrastructural and immunohisto-
chemical studies [1]. The tumor is located predominantly
in the mid-portion of the tibia. The cases do occur simul-
taneously in tibia and in adjacent fibula or may occur in
fibula with out involvement of tibia. It is a rare neoplasm,
comprise only 0.1–0.5% of all primary bone tumors [2].
The first reported example is attributed to Maier in 1900
[3]. In 1913, Fischer [4] named the lesion "primary ada-
mantinoma of the tibia" because of its striking histologic
resemblance to the jaw "adamantinoma" (ameloblast-
oma). In 1951, Schulenberg [5] suggested a unifying his-
togenetic concept for the adamantinomas of the
appendicular skeleton.
Origin
In the past there has been much speculation about the ori-
gin of adamantinoma. Several hypotheses have been pro-
posed for its histogenesis [4,6-22] (Table 1). Fischer [4]
has suggested congenital implantation of epithelial cells
whilst Ryrie [6] and Dockerty and Meyerding [7] favoured
traumatic implantation. These suggestions have been crit-
icized by Lederer and Sinclair [9], and Naji [10], who sug-
gested a synovial origin. Although vascularity is not a
striking feature of this tumor, at times these tumors can be
very vascular, and it is the vascularity which is responsible
for the fact that some authors regard these tumors as
angioblastomas [11-14]. The etiology of the tumors is still
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a matter of debate but the most widely adopted theory is
that of displacement of basal epithelium of skin during
embryological development and is supported by the pre-
dominant involvement of anterior tibia, where enchon-
drally formed bone is closest to the skin surface [2]. It
seems to suggest that adamantinoma is a tumor of epithe-
lial origin. Based on ultrastructural and immunohisto-
chemical studies, the tumor cells show strong positive
staining with pan-cytokeratin antibody immunohisto-
chemically [19] and by electron microscopy the cells have
epithelial characteristics such as basal lamina, desmo-
somes, gap junctions, epithelial specific keratin and extra-
cellular composition similar to epithelial tissue [23]. The
possible relationship of adamantinoma to osteofibrous
dysplasia is the subject of conflicting discussions and the
potential link has implications for the diagnosis, progno-
sis, and treatment [2,24].
Clinical features
Adamantinoma mostly occurs in the second to fifth dec-
ade. The median patient age is 25 to 35 years, with a range
from 2 years to 86 years. It is slightly more common in
men than women, with a ratio of 5:4 [25]. It rarely occurs
in children with only a total of 119 pediatric patients, 65
boys and 54 girls reported in the medical literature
searched in Pubmed-listed journals and Google [1,26].
The tumor has a striking predilection for the long bones
(97 percent of cases) and, specifically, the tibia (80 to 85
percent of cases), represents the most characteristic clini-
cal feature of this tumor. In 10 to15%, the lesion is also
found in the ipsilateral fibula [27]. Statistically, the tumor
remains unusually prevalent in the tibia, but all other
major limb bones have been involved, and involvement
of several short bones rarely has been reported [28]. Other
bones that are involved, in order of decreasing frequency,
include the humerus [29], ulna [30], femur [31], fibula
[8], radius [32], innominate bones [33], ribs [34],
spine[35] and rarely small bones of the hand and foot
[36]. There have been only six cases of spinal adamanti-
noma reported [35]. There are extremely rare reports of
adamantinomas arising exclusively from the pretibial soft
tissues without any bony involvement [37,38].
The initial symptoms of adamantinoma are often indo-
lent and nonspecific and depend on location and extent
of the disease. The onset is insidious and its course shows
a slow, progressive character. The patient often tolerates
symptoms for many years before seeking medical atten-
tion. A history of significant trauma has been noted in
about 60% of 200 cases reviewed by Moon and Mori [25].
Most patients present with swelling with or without pain.
The patient may presents with bowing deformity of the
tibia due to involvement of anterior tibial surface. Patho-
logical fracture may be present in as many as 23% of the
patients [39]. There have been two case reports of parane-
oplastic hypercalcemia associated with tibial adamanti-
noma and pulmonary metastasis [40,41]. Spinal lesions
may be manifested by neurologic symptoms in addition
to pain [35].
Radiology
Radiographically adamantinoma of bone displays fea-
tures that are somewhat characteristic and help in estab-
lishment of presumptive diagnosis because of tumor's
classic location and appearance. In the tibia, it usually
appears as a central or eccentric, multilocular because of
the sclerotic margins of overlapping radiolucencies,
slightly expansile, sharply or poorly delineated osteolytic
lesion. As previously stated, in long bones it is found in
the diaphyseal location although metaphyseal extension
of lesions or isolated involvement of a metaphysis is seen
occasionally. The metaphyseal involvement makes the
diagnosis more challenging because other tumors have to
be considered in the differential diagnosis. The lesions are
well-circumscribed involving anterior tibial cortex, with
septations and peripheral sclerosis. Multifocality in the
same bone is regularly observed. These multifocal radiolu-
cencies surrounded by ring-shaped densities producing
the characteristic "soap-bubble" appearance. The lesion is
commonly intra-cortical, but may destroy cortex and
invade the extracortical soft tissues in about 15% of cases
Table 1: Theories of origin of Adamantinoma
Theory Authors, year
1. Fetal crest Fischer, 1913 [4]
2. Basal cell lineage, Trauma Ryrie, 1932 [6]
3. Implantation Dockerty and Meyerding, 1942 [7]
4. Unknown Baker et al, 1954 [8]
5. Synovial cell like Lederer and Sinclair, 1954 [9], Naji et al 1964 [10]
6. Angioblastic Changus et al, 1957, Elliot 1962, Llombart bosch and Ortuno-pacheco, 1978, Reed, 1982 [11-14]
7. Mesenchymal Vinogradova, 1969 [15]
8. Dermal inclusion Lichtenstein, 1977 [16]
9. Epithelial cell Jaffe, 1958, Saacebra et al, 1968, Rosai and Pincus,1982, Ishida et al,1992, Hazelbag et al, 1993, Jundt et al, 1995 [17-
22]Diagnostic Pathology 2008, 3:8 http://www.diagnosticpathology.org/content/3/1/8
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[1]. The entire lesion may have a prominent sclerotic mar-
gin indicative of slow growth. The periosteal reaction is
variable from minimal to prominent [23].
Radiologically, the differential diagnosis of adamanti-
noma should include osteofibrous dysplasia and fibrous
dysplasia. Distinguishing osteofibrous dysplasia and
fibrous dysplasia from adamantinoma may be difficult;
however, diaphyseal location, involvement of the anterior
cortical bone with extension toward the bone marrow,
single or multiple nodular lesions in one or more foci,
and intense and homogeneous enhancement may con-
tribute to the diagnosis of adamantinoma. OFD is specif-
ically located in the cortex without involvement of the
medullary canal [42].
Computed Tomography (CT) and Magnetic Resonance
Imaging (MRI) have been used to study the lesions of ada-
mantinoma and usually the findings are not specific. CT
scan shows the cortical involvement and the soft tissue
extension when it exist. However, does not show the intra-
osseous extension of the tumour. CT does play a role in
detecting pulmonary metastases and as such plays a role
in the routine work-up [1].
MRI is pivotal for precise locoregional staging, especially
for depiction of distant cortical foci, soft tissue, and
intramedullary extension and thus is useful for determin-
ing tumor-free margins and strategies for reconstructive
surgery. Van der Woude et al described two morphologi-
cal patterns on MR imaging: a solitary lobulated focus ver-
sus a pattern of multiple small nodules in one or more
foci. If MRI scanning is used to study adamantinomas, the
tumors demonstrate low signal intensity on T1-weighted
spin echo images and high signal on T2-weighted images.
Because these appearances are also typical of most
tumors, these findings are nonspecific [43].
Use of nuclear medicine to study adamantinomas is a rel-
atively new undertaking. The following findings corre-
spond to adamantinomatous lesions: increased blood
flow in the region of the tumor, increased blood pooling,
and increased accumulation of technetium-99m methyl-
ene diphosphate in the area of the tumor. In addition,
bone scan may show a coexisting fibular involvement
[44].
Pathology
Histologically, the classic adamantinoma is a biphasic
tumor and characterized by epithelial and osteofibrous
components that may be intermingled with each other in
various proportions and differentiating patterns. Ada-
mantinoma is classified into 2 distinct types: classic and
differentiated. Classic adamantinoma usually occurs in
patients older than 20 years, whereas differentiated ada-
mantinoma (Osteofibrous dysplasia (OFD) – like/regres-
sive/juvenile/intracortical adamantinoma) occurs almost
exclusively in patients younger than 20 years [45]. In addi-
tion, the two subtypes of adamantinoma have distinct
radiographic and histologic differences (Table 2).
Classic adamantinoma is in general characterized by
admixture of both epithelial and osteofibrous compo-
nents that are associated with various proportions and dif-
ferentiation patterns. OFD-like adamantinoma is
characterized by predominance of osteofibrous tissues, in
which small groups of epithelial cells are only detected by
careful search or immunohistochemistry.
Gross appearance
The appearance varies but most often the tumor is yellow
gray or grayish white and fleshy or firm in consistency.
Some OFD like adamantinomas are more solid because of
the presence of relatively large bone forming areas. Occa-
sionally tumors show macroscopic cysts range from a few
millimeters to centimeters in diameter. These cystic spaces
contain a straw colored or blood like fluid on gross exam-
ination [46].
Microscopic examination
The neoplastic cells of the classic adamantinoma range
from small to large in size with finely dispersed chromatin
and an overall bland appearance. A few cases from a large
series have exhibited nuclear atypia. Mitotic figures are
usually infrequent, most reporting 0–2 mitoses per 10
high power fields [27,47]. Several patterns of growth have
been described such as tubular, basaloid, squamous, spin-
dle-cell, and osteofibrous dysplasia-like variant. In classic
adamantinomas, the most common form consists of solid
Table 2: Classification of Adamantinoma
Features Classic Differentiated
Age More than 20 years, Adults Less than 20 years, Children
Radiology Soft tissue or intramedullary involvement regularly 
observed
Intra cortical location indistinguishable from OFD
Histopathology Admixture of both epithelial and osteofibrous component, 
most commonly solid nests of basaloid cells
OFD like pattern lacks conspicuous nests and masses of epithelial 
cells. Scattered positivity of epithelial elements for cytokeratin
Behavior Aggressive clinical course Relatively benignDiagnostic Pathology 2008, 3:8 http://www.diagnosticpathology.org/content/3/1/8
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nests of basaloid cells (Fig 1 &2). Tubular adamantinomas
are consisted of narrow cords of epithelial cells with cen-
tral discohesion resulting in a vascular or glandular
appearance. In the basaloid variant, the epithelial cells
exhibit solid nests of basaloid cells with distinctive
peripheral palisading. The squamous variant with or with-
out keratinization may resemble well differentiated squa-
mous cell carcinoma. The spindled form shows uniform
spindling with presence of clefts lined by epithelial cells.
The histologic features of differentiated adamantinoma
are predominantly characterized by a pattern of osteofi-
brous dysplasia [45].
Foci of calcification [48], giant cells [8], xanthoma and
spindle cells [49] have all been also described in adaman-
tinoma. Sarcomatous dedifferentiation of the epithelial
component has been described by Hazelbag et al [50]. In
addition a rhabdoid variant of differentiated adamanti-
noma has been reported by Povysil et al [51].
Relationship between adamantinoma and OFD
It has been postulated that the predominance of an oste-
ofibrous dysplasia-like pattern in differentiated adamanti-
noma is the result of a secondary reparative process
overgrowing matured and regressing tumor tissue. It is
possible that this process may lead to the total elimina-
tion of recognizable tumor cells from the lesion. There-
fore, osteofibrous dysplasia, which has a similar anatomic
location, age distribution, and radiologic appearance as
differentiated adamantinoma, may, in some cases, repre-
sent the evolution of an underlying adamantinoma. Anal-
ysis suggests that long bone adamantinoma could be
another member of the unique family of tumors that may
regress spontaneously [45].
Because some osteofibrous dysplasia-like tumors have
progressed to classic adamantinomas, it is hypothesized
that the former is a potential precursor of the latter, show-
ing mesenchymal-to-epithelial transformation. There are
two cases reported in the literature of progression from
differentiated to the classic type [47]. There have been
controversies as to the potential correlation among classic
adamantinoma, osteofibrous dysplasia-like adamanti-
noma and osteofibrous dysplasia, all of which originate
mainly in the tibial cortex and have close radiographic
and histological similarities.
A probable histogenetic relationship exists between the
three entities. Indeed, the only apparent difference
between osteofibrous dysplasia and differentiated ada-
mantinoma is the presence of an epithelial component
readily identifiable on routine hematoxylin and eosin
stained sections and their identification only by immuno-
histochemical means in about 80% of osteofibrous dys-
plasia lesions (Table 3).
Czerniak et al [45] proposed the existence of a continuum
of fibro-osseous lesions with osteofibrous dysplasia at one
end of the spectrum, classic adamantinoma at the other,
and differentiated adamantinoma intermediately. This
hypothesis is also supported by other authors [52,53].
Mirra [2] considered this possible relationship by calling
osteofibrous dysplasia "juvenile adamantinoma". This
concept, however does not rule out the possible existence
of de novo osteofibrous dysplasia not related to adamanti-
noma. Sweet et al [54] studied 30 cases of osteofibrous
Higher magnification to show hyperchromatic cells with  moderate nuclear pleomorphism H & E × 600 Figure 2
Higher magnification to show hyperchromatic cells 
with moderate nuclear pleomorphism H & E × 600.
An adult female presented with pain in the right lower leg Figure 1
An adult female presented with pain in the right 
lower leg. On imaging, a cortical lytic lesion was seen in the 
lower end of tibia. Photomicrograph to show solid nests of 
basaloid cells embedded in a fibrous stroma H & E × 400.Diagnostic Pathology 2008, 3:8 http://www.diagnosticpathology.org/content/3/1/8
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dysplasia to determine whether it is a precursor lesion to
adamantinoma. They concluded that there was no conclu-
sive evidence of a precursor role for osteofibrous dyspla-
sia. However cytogenetic studies have demonstrated
similar alterations in the two lesions [55].
Relationship between adamantinoma and Ewing's 
sarcoma
Recently, the least common variant of adamatinoma has
been described as Ewing's-like adamantinoma or ada-
mantinoma-like Ewing's. The variant is characterized by
anastomosing cords of small, uniform, round cells set in
a myxoid stroma. These cells exhibit features of both epi-
thelial cells and neuroendocrine cells on ultrastructural
examination. Immunohistochemical studies have shown
the tumor cells to contain both epithelial and neural anti-
gens including the Ewing's sarcoma-related antigen
[56,57]. Bridge et al [52] documented 11;22 translocation
in the nuclei of cytokeratin-immunoreactive cells, and
therefore considered the tumors to be variants of Ewing's
sarcoma rather than Ewing-like adamantinoma. They
termed the lesion "adamantinoma-like Ewing's sarcoma".
In contrast, Hauben et al. reported that 12 cases of ada-
mantinoma lacked both EWS-FLI-1 and EWS-ERG fusion
transcripts [58]. Folpe et al. described three cases of "ada-
mantinoma-like" Ewing's sarcoma showed a distinctly
nested, epithelioid growth pattern with surrounding
desmoplasia, and characteristically expressed high molec-
ular-weight cytokeratins and pan-cytokeratins with
genetic confirmation [59]. Recently Fujii et al reported a
case of adamantinoma-like Ewing's sarcoma with EWS-
FLI1 fusion gene [60]. The histogenesis of this lesion is
not clear; however, Ewing's sarcoma is considered to be
derived from primitive, pluripotential stem cells that may
differentiate into cells with mesenchymal, epithelial, and
neuronal features. This may result in expression of pheno-
types showing both epithelial and neuroectodermal dif-
ferentiation in Ewing's sarcoma. These data indicate that
tumors showing overlapping morphological and immu-
nohistochemical features can be readily distinguished
with molecular techniques. Appropriate treatment of this
lesion has not yet been established, but standard pre- and
postoperative chemotherapy and wide surgical excision
for Ewing's sarcoma has been recommended. Recently,
the risk-adapted treatment strategy including high dose
chemotherapy (HDCT) with peripheral blood stem cells
transplantation (PBSCT) has been proposed [61]. How-
ever, previous studies demonstrated that HDCT with
PBSCT in the treatment of Ewing's sarcoma have limited
benefits [62,63]. Further study will be needed to clarify
the differences of prognosis and chemosensitivity
between conventional Ewing's sarcoma and "adamanti-
noma-like Ewing's sarcoma".
Immunohistochemistry
Regardless of histologic subtypes, all adamantinomas
have been uniformly positive for keratins 14 and 19 [21].
Immunohistochemically, the epithelial cells show coex-
pression of keratin, especially basal epithelial cell keratins
(CKs 5, 14 and 19) and vimentin [64] (Fig 3). The keratin
Table 3: Differences between Osteofibrous dysplasia and Adamantinoma
Features Osteofibrous dysplasia Adamantinoma
Nature Benign condition Locally aggressive
Age Less than 10 years 2 year to 86 years
Site May involve both tibia and fibula. 90% tibial involvement, In 10–15% cases, ipsilateral fibular 
involvement, Rarely pretibial soft tissue and other bones
Clinical presentation • Pain, swelling, pseudoarthrosis, bowing, 
pathological fracture may occur
• With or without Pain, swelling, pathological fracture in 
25% cases
• seldom progresses during childhood, and any 
progression of the lesion stops after puberty
• progressive during adult age
Predisposing history of trauma Absent Present
Radiology Periosteal reaction present Periosteal reaction is variable
Intra cortical 15% of cases, there is extracortical extension into soft 
tissues
Limited to anterior cortex Single or multiple nodular lesions in one or more foci in 
medulla
Well marginated with marginal sclerosis, ground 
glass appearance
Sharply or poorly delineated osteolytic lesion. with 
septations and peripheral sclerosis, characteristic "soap-
bubble" appearance
Histopathology Zonal phenomenon present
Scattered epithelial cells recognized on IHC
Absent
Presence of epithelial cells forming small nests/strands 
recognized in H&E
Recurrence Local recurrence in 25%. Tends to recur in 18–32%
Metastasis No metastasis Metastases may occur in 15–30%, Lung and Lymph nodes 
usually involved
Regression Spontaneous regression at puberty in 33% cases Regression ± [45]Diagnostic Pathology 2008, 3:8 http://www.diagnosticpathology.org/content/3/1/8
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immunoreactivity pattern is independent of histologic
subtype, despite marked variety in differentiation pattern,
suggesting a common histogenesis for all subtypes of ada-
mantinoma. Furthermore, the pattern is conserved both
in local recurrences and in metastasis. The pattern differs
significantly from other bone and soft tissue tumors with
known epithelial characteristics, e.g., synovial sarcomas,
chordomas, and epithelioid sarcomas, in that it lacks
immunoreactivity of keratins 8 and 18. Therefore a basal
epithelial cell-like differentiation of adamantinomas is
suggested [21].
There is still debate as to whether the fibrous part should
be designed as a benign neoplastic element of a biphasic
tumour or as a reactive non-neoplastic tissue next to an
epithelioid bone tumour. Bovee et al [65] examined the
relationship between the epithelial and the stromal com-
ponents of adamantinomas by comparing the immuno-
histochemical expression of the proliferation marker Ki-
67, epidermal growth factor and epidermal growth factor
receptor and fibroblast growth factor type 2 in the two cell
populations. These antigenic factors were present either
exclusively or predominantly in the epithelial compo-
nent, suggesting that the epithelial component constitutes
the primary proliferating neoplastic cell population that is
able to stimulate a reactive fibrous growth. Additional
studies by Hazelbag et al [66] utilizing DNA flow cytome-
try and p53 immunohistochemistry demonstrated aneu-
ploidy and significant p53 immunoreactivity only in
nuclei of cells of epithelial phenotype. Furthermore, in
several cases with pulmonary metastasis, only cytokeratin-
positive epithelial cells and not the osteofibrous stromal
component were detected in the metastatic lesions. These
results suggested that either adamantinoma consists of a
malignant epithelial part with a reactive osteofibrous
stroma or that the malignant epithelial cells develop next
to a proliferating benign fibrous component.
Maki and Athanasou [67] correlated proto-oncogene
product and matrix protein expression in osteofibrous
dysplasia and adamantinoma. They found C-fos and c-
jun, expression in OFD and in the fibrous and epithelial
components of differentiated and classical adamantino-
mas. Staining for collagen IV, laminin and galectin-3, was
seen in OFD and around cell nests in adamantinoma.
However E-, P-, and N-cadherin expression was found
only in classical adamantinoma. Osteonectin was
detected in both the epithelial and fibrous components of
adamantinomas, but osteopontin and osteocalcin were
not seen in classical adamantinomas. The results show
common expression of a number of oncoproteins and
bone matrix proteins in adamantinoma and OFD.
Cytogenetics
Cytogenetic analysis has contributed greatly to the under-
standing of the histopathogenesis of adamantinoma and
osteofibrous dysplasia. Unfortunately, because of their
rarity, cytogenetic reports concerning these tumors are
few. Review of previously reported cases reveal extra cop-
ies of chromosomes 7, 8, 12, 19, and/or 21 in classic and
differentiated adamantinoma [55,68-70]. Extra copies of
one or more of these same chromosomes with the excep-
tion of chromosome 19 have also been seen in osteofi-
brous dysplasia, lending further support to an
osteofibrous dysplasia/adamantinoma relationship. Vari-
ous studies related to cytogenetic analysis in adamanti-
noma are described in Table 4.
Cytopathology
There are several publications that confer the radiologic,
clinical, and histopathologic features of adamantinoma;
on the contrary, only few cases of the cytologic findings of
adamantinoma are found [71-76]. Cytologic features of
adamantinoma in various studies have been reviewed and
described in Table 5.
Differential diagnosis
Because of its rarity and differing clinicoradiologic and
histological patterns, adamantinoma may resemble
numerous conditions (Table 6).
Behavior
Adamantinomas are locally aggressive tumor and are
extremely slow growing with the potential to metastasize.
Recurrence of tumor is frequent after inadequate therapy,
and the behavior of the recurrent neoplasm resembles
more and more that of a sarcoma. This low-grade, slowly-
growing malignancy metastasizes in about 15–30 percent
of cases by both hematogenous and lymphatic routes to
Immunohistochemistry for cytokeratin shows strong positiv- ity with in the tumor cells × 600 Figure 3
Immunohistochemistry for cytokeratin shows strong 
positivity with in the tumor cells × 600.Diagnostic Pathology 2008, 3:8 http://www.diagnosticpathology.org/content/3/1/8
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other parts of the body, usually to the lungs or nearby
lymph nodes; bone and abdominal viscera make up a
minority [25,27,65,77]. Although exhibiting varying his-
tological patterns, no correlation between histology and
clinical course was seen. However, Theros and Ishak [78]
reported that the more malignant the lesion is, the less
distinctive the honeycomb pattern. Some investigators
think that the Ewing's sarcoma-like variant of conven-
tional adamantinoma, is accompanied by more aggressive
behavior and a poorer prognosis [56]. In addition intra-
lesional treatment, male patient, pain at presentation,
short duration of symptoms, young age (less than 20
years) and lack of squamous differentiation of tumor
seem to influence an unfavorable clinical outcome [77].
Local recurrence rate varies from 18–32% [27,65].
Although ascertaining accurate mortality statistics is diffi-
cult because of the extremely rare nature of this tumor,
mortality rates of 13% to 18% have been reported
[25,27].
Treatment
Current treatment of adamantinoma, including en bloc
tumor resection with wide operative margins with limb
reconstruction and limb salvage, provides lower rates of
local recurrence than has been previously reported [27].
Quereshi et al reported in a review of 70 patients, en bloc
tumor resection with wide margins and limb salvage was
shown to have 10 year survival rate of 87.2% [39]. Ampu-
tation for adamantinoma has not been shown to improve
survival when compared with the limb preserving surgery
but may be advisable if local recurrence occur or if en-bloc
resection and limb salvage is not an option. The limb
reconstruction can be performed with distraction osteo-
genesis, allografts, vascularised fibular autografts (pre-
ferred) and metallic segmental replacement [23].
Unfortunately neither radiation therapy nor chemother-
apy has been proven effective in the treatment of this
insidious tumor [28].
Conclusion
Although the incidence of adamantinoma is low, it is
important to recognize this rare bone tumour, since in
Table 5: Cytopathology of Adamantinoma
Author Age of patient Site of tumor Behavior of tumor Cytologic features
Hales and Ferrell [71] NA Tibia Primary Peripheral palisading, and prominent extracellular hyaline-like 
material
Galera-Davidson, et al [72] 31 Tibia Recurrent Single-lying cells, small clusters and Indian files, with some 
nuclear molding. Three cell types (1) large polygonal cells with 
chromatin clearing, (2) smaller cells with poorly defined 
cytoplasm and dense chromatin and (3) fusiform cells
Laucirica, et al [73] 25/M Tibia Primary Numerous sheets and single cytologically bland spindle cells 
with "chromatinic membrane folds"
Perez-Ordonez and Bedard 
[74]
Two cases Lung Metastatic Small round and spindle cells with indistinct cytoplasm. The 
nuclei had delicate nuclear membranes, with finely dispersed 
chromatin and occasional micronucleoli. No pleomorphism.
Tabei, et al [75] One case Lung Metastatic Clusters of small cells with either prominent nucleoli or 
spindle-shaped hyperchromatic nuclei.
Flowers et al [76] One case, 32/
M
Tibia, Lung Recurrent and 
metastatic
Numerous nuclear membrane grooves within the polygonal 
cells
NA: Not available
Table 4: Cytogenetic findings in Adamantinoma
Author Type of adamantinoma Karyotype
Mandahl et al [68] Classic 46,XX,t(1;13;22), t(15;17)
Sozzi et al [69] Classic 52,XY +7,+12,+13,+19,+der(7), +der(13)
Hazelbag et al [70] Classic 50,XY,+7,+8,+12,+19
Classic 50,XY,+7,+8, +12,+19
Classic 51,XY,+X,+7,+12,+19,+21/50,
Differentiated 48,XY,+7,+8
Differentiated 46,XX,t(2;11), inv(11)
Kanamori et al [55] Classic 54,XX,-1,+5,+der(7),+der(8), +der(9),+19,+20,+21,+mar1,+mar2
Classic 7,8,12,19 extra copies
Classic 7,8,12,19 extra copies
Differentiated 54,XY,+5,+7,+8,+12,+12,+14,+19,+21/53D
i
a
g
n
o
s
t
i
c
 
P
a
t
h
o
l
o
g
y
 
2
0
0
8
,
 
3
:
8
h
t
t
p
:
/
/
w
w
w
.
d
i
a
g
n
o
s
t
i
c
p
a
t
h
o
l
o
g
y
.
o
r
g
/
c
o
n
t
e
n
t
/
3
/
1
/
8
P
a
g
e
 
8
 
o
f
 
1
1
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 6: Differential diagnosis of Adamantinoma
Lesions Age 
(yrs)
Sex M:F Site Location Clinical Features Radiological 
Features
Gross Microscopy IHC Treatment Remarks
Aneurrysmal bone 
cyst
10–15 1:1 Vertebrae, flat 
bones, humerus, 
tibia
Metaphysis Usually history of 
trauma, f/b 
gradually increasing 
swelling with little 
pain. There may be 
pathological 
fracture or spinal 
pressure symptoms
Well defined 
radiolucent, eccentric 
cyst
Spongy 
hemorrhagic 
mass
Fibrous tissue, vascular 
spaces
IGF-1 Curettage with 
bone grafting
May heal 
spontaneously 
Benign
Unicamaral bone 
cyst
10–20 3:1 Humerus, femur Metaphysis Usually 
asymptomatic
Well demarcated, 
radiolucent cyst 
extending up to 
physeal plate
Cystic mass Well vascularised 
fibrous tissue with 
hemosiderin and 
cholesterol clefts
NA Curettage with 
bone grafting
Benign
Fibrous dysplasia 10–30 3:2 Neck of femur, 
tibia, base of skull
Metaphysis 
diaphysis
May be mono or 
polyostotic, 
pathological 
fractures and 
progressive 
deformity
Cystic areas in 
metaphysis, lucent 
patches typically have 
ground glass 
appearance
Coarse gritty, 
Grayish yellow
Loose cellular fibrous 
tissue with widespread 
patches of woven bone 
and scattered giant 
cells
NA Depending upon 
location and type 
of deformity
Locally 
aggressive, 
rarely sarcoma 
Develops, 
Associated 
Albright 
syndrome
Chondromyxoid 
Fibroma
10–25 1:1 Tibia, fibula, 
femur, feet, pelvis
Metaphysis Asymptomatic, 
pathological 
fracture
Eccentrically placed 
lytic lesion with well 
defined sclerotic 
margins
Solid yellowish 
white or tan
Patches of 
myxomatous tissue 
with stellate cells, 
islands of hyaline 
cartilage, fibrous tissue
S-100 Excision Benign
Giant cell tumor 20–40 4:5 Epiphysis and 
metaphysis
Femur, tibia, radius Pain with swelling, 
pathological 
fracture
Eccentric, cystic lesion 
in mature bone, 
extending up to the 
subchondral plate, 
soap bubble 
appearance
Reddish fleshy 
mass
Multinucleated giant 
cells, stromal cells, 
cellular atypia with 
mitotic figures
Muscle actin, 
alpha-smooth 
muscle actin and 
CD68
Depending upon 
severity of lesion, 
curettage with 
bone graft to 
excision
Potentially 
malignant, 50% 
recur, 10% 
metastasize
Eosinophilic 
granuloma
5–10 2:1 Metaphysis Flat bones, 
mandible, spine 
and long bones
Local pain, swelling 
and tenderness
Well demarcated oval 
radiolucent area, 
associated with 
marked reactive 
sclerosis
Soft, granular or 
gelatinous mass
Sheets of Langerhan's 
cells
CD-1a, S-100 Excision or 
curettage
Usually heals 
spontaneously
Osteomyelitis Any age Male 
outnumbe
rs female
Metaphysis, 
diaphysis
Distal femur, 
proximal tibia, 
proximal femur 
and proximal 
humerus
Discharging sinus, 
fever, malaise, local 
pain and swelling
Multiple aggressive 
lytic lesions, 
serpiginous lytic 
pattern is more 
specific sequestrum 
and involucrum are 
often seen
Bone 
destruction, 
cavities 
containing pus 
with sequestrum
Inflammatory cells 
around areas of 
acellular bone or 
microscopic sequestra, 
prominent periosteal 
bone proliferation
NA Removal of 
sequestrum 
antibiotic, 
excision of 
sinuses
Variable 
prognosis
Chondrosarcoma 30–60 3:1 Metaphysis Pelvis, rib, 
humerus, femur, 
vertebrae
Dull ache or 
gradullay enlarging 
lump
Radiolucent area with 
central flecks of 
calcification
Lobulated with 
gelatinous shiny 
areas
Lobules of highly 
atypical cells, including 
binucleate cells.
S-100, Vimentin Wide excision Malignant
Epithelial 
metastasis
Any 
age
Variable Pattern of 
these lesions is 
more diffuse 
than regional
Vertebrae, 
pelvis, rib, 
femur, skull, 
humerus(rare 
below elbow 
and knees)
Pain Bone destruction, 
osteolytic; 
osteoblastic 
response with Ca 
prostate
Osteolytic, 
rarely sclerotic
Malignant cells with 
vascular invasion
Depend on 
the site of 
primary
Osteoclast 
inhibiting 
agents, 
radiation 
therapy
Most 
common 
primaries 
breast, 
prostate, 
lung, kidney, 
and thyroidD
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Hemangioendo
thelioma
20–30 2:1 Metaphyseal, 
diaphyseal, or, 
less 
commonly, 
epiphyseal.
Calvarium, 
femur, tibia and 
feet
Pain and 
swelling
Expansive, 
osteolytic and 
poorly demarcated 
lesions. "soap-
bubble" matrix 
with a sclerotic 
margin
Well-
circumscribed, 
irregular 
borders soft, 
bright red 
hemorrhagic 
appearance
Solid nests and 
anastomosing 
cords of round, 
polygonal, or 
spindle-shaped cells 
with eosinophilic 
cytoplasm. 
Intracytoplasmic 
vacuolization
Factor VIII, 
CD31, CD34
Depending on 
the grade of 
the lesion 
currettage, or 
wide resection
Multifocal in 
up to 50% of 
cases and 
may be 
mono-ostotic 
or 
polyostotic 
locally 
aggressive, 
metastasize 
to bone and 
lung
Angiosarcoma Any age Older 
male
Metaphyseal and 
diaphyseal
Any bone, 
multifocal
Pain and swelling Eccentric, lytic, 
metaphyseal and 
diaphyseal, well 
circumscribed areas of 
rarefaction
Variable Anastomosing vascular 
channels lined by highly 
atypical endothelial 
cells
Factor V11I, 
CD31, CD34
Wide 
resection and 
adjuvant 
therapy
Malignant
Nonossifying 
fibromas
10–20 1:1 Tibia, femur Metaphysis Pain Eccentric, sharply 
delimited lesion
Solid, Granular, 
brown, dark red
Fibrous tissue arranged 
in storiform pattern, 
foamy and hemosiderin 
laden macrophages
Little or no 
application
Not necessary Benign
ABBREVIATION: IGF: Insulin like growth factor, IHC: Immunohistochemistry, f/b: followed by, NA: Not applicable
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early stages of the disease adequate treatment will result in
an excellent prognosis. The histologic features of primary
adamantinoma are usually characteristic enough for a pre-
sumptive diagnosis; however, the rarity and the heteroge-
neity of the tumor could pose diagnostic uncertainty in
some cases, especially those arising in non-tibial loca-
tions. Extensive sampling of the lesion is important, espe-
cially in the differentiated adamantinoma where the
epithelial component may be seen only focally. To assure
the histological diagnosis pathologists should employ
immunohistochemistry for demonstrating the sometimes
sparse epithelial cell nests when radiology is suggestive for
adamantinoma. Correct diagnosis should lead to resec-
tion with wide surgical margins.
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